en
E-mail us
Crystal Pharmatech Recognized as
07 Jul 2023
Crystal Pharmatech Recognized as "Best Partner" by Allorion Therapeutics for Excellent Services
Suzhou, China - July 7, 2023 - Crystal Pharmatech, a leading pharmaceutical technology company, has received dual recognition from its esteemed partner, Allorion Therapeutics (Boston, US / Guangzhou, ...
Crystal Formulation Services' GMP Manufacturing Facility Successfully Passes the Remote Audit by US Client, Marking a Key Milestone for Its International Expansion
12 May 2023
Crystal Formulation Services' GMP Manufacturing Facility Successfully Passes the Remote Audit by US Client, Marking a Key Milestone for Its International Expansion
Today, Crystal Pharmatech announced that the GMP manufacturing facility of their CDMO business unit – Crystal Formulation Services (CFS) has successfully passed a remote audit conducted by a US clien...
Crystal Pharmatech's CDMO Business Unit - Crystal Formulation Services Received China Drug Product Manufacturing License, Achieving the Important Milestone in Formulation Capability
27 Mar 2023
Crystal Pharmatech's CDMO Business Unit - Crystal Formulation Services Received China Drug Product Manufacturing License, Achieving the Important Milestone in Formulation Capability
Crystal Formulation Services, a subsidiary of Crystal Pharmatech, has achieved an exciting new milestone in its formulation capabilities. The company was recently granted the "Drug Manufacturing ...
Candoo's Formulation Technology Platform Featured in the Drug Development & Delivery Journal
09 Mar 2023
Candoo's Formulation Technology Platform Featured in the Drug Development & Delivery Journal
Crystal Pharmatech, the leading solid state research CRO, is proud to announce that the formulation platform of its subsidiary Candoo Pharmatech Company Inc. to address solubility and bioavailability ...
Industry Shift: FDA Goes Vegan?
22 Feb 2023
Industry Shift: FDA Goes Vegan?
Approaching Drug Development With FinesseIn 2012, drug development specialists started an initiative to create predictive Oral Bioavailability Tools (OrBiTo). This initiative recognized the need to mo...
Crystal Pharmatech Returned to AAPS 2022 PharmSci 360
25 Oct 2022
Crystal Pharmatech Returned to AAPS 2022 PharmSci 360
Crystal Pharmatech returned to the American Association of Pharmaceutical Scientists (AAPS) 2022 PharmSci 360 conference alongside pharmaceutical industry players, buyers, and suppliers.
Crystal Formulation Services(CFS)Opens New Formulation Development Center and Analytical R&D Lab in Suzhou, China
29 May 2022
Crystal Formulation Services(CFS)Opens New Formulation Development Center and Analytical R&D Lab in Suzhou, China
We have both formulation laboratory and pilot GMP-like workshop equipped with a number of international top equipments for oral solid dosage development. The formulation laboratory is mainly used for ...
Crystal Formulation Services, Formulation Tailor-made for Your Molecules
22 Apr 2022
Crystal Formulation Services, Formulation Tailor-made for Your Molecules
Crystal Pharmatech, the leading solid state research CRO, is proud to announce the opening of a novel, small molecule, formulation CDMO subsidiary known as Crystal Formulation Services (CFS).Crystal P...
Candoo Enables the Successful Development of a BCS 4 Combo Drug Product
14 Jan 2022
Candoo Enables the Successful Development of a BCS 4 Combo Drug Product
This milestone further demonstrates Candoo's expertise in formulation and biopharmaceutics to achieve bioequivalence among different polymorphs and/or salts. For new chemical entities (NCE), it is...
Crystal Pharmatech Expands Leadership Team
04 Jun 2020
Crystal Pharmatech Expands Leadership Team
Crystal Pharmatech, INC is honored to announce it has hired Dr. Rositza Petrova to Head up US Research and Development efforts. Rosie will report directly to the Head of US Operations and work closely...
International Company Crystal Pharmatech Finds CCIT An Optimal Spot for First US Location
04 Aug 2017
International Company Crystal Pharmatech Finds CCIT An Optimal Spot for First US Location
TRENTON (August 4, 2016) – In addition to the dozens of New Jersey entrepreneurs who have used the New Jersey Economic Development Authority's (EDA) Commercialization Center for Innovative Techno...
Crystal Pharmatech Raises $10 Million to Accelerate Growth
22 Sep 2015
Crystal Pharmatech Raises $10 Million to Accelerate Growth
On September 15, 2015, Crystal Pharmatech Co., Ltd. Announced the completion of raising $10 million in Series A funding led by Renner Lian he Holdings. Crystal Pharmatech will use the funds to further...
Crystal Pharmatech Triples Headquarters in Biobay, China, with More Floors and Labs
17 Aug 2013
Crystal Pharmatech Triples Headquarters in Biobay, China, with More Floors and Labs
(Suzhou, China) July 16, 2013-Crystal Pharmatech, a leading contract research organization (CRO) which focuses on solid state information for active pharmaceutical ingredients and formulations, has mo...
Crystal Pharmatech and Particle Sciences Form a US-China Pharmaceutical CRO Partnership
04 Mar 2013
Crystal Pharmatech and Particle Sciences Form a US-China Pharmaceutical CRO Partnership
By Damain GardeFrom Fierce BiotechPRINCETON, N.J. & SUZHOU, China--Crystal Pharmatech, a technology-driven solid-state research contract research organization (CRO) based in Suzhou, China, announc...
Xceleron and Crystal Pharmatech Announce Partnership to Improve Early Clinical Development Utilizing Absolute Bioavailability Trials and Solid-State Solutions
22 Jan 2013
Xceleron and Crystal Pharmatech Announce Partnership to Improve Early Clinical Development Utilizing Absolute Bioavailability Trials and Solid-State Solutions
Xceleron, a U.S.-based leader in the application of ultra-sensitive analytical technology to novel clinical designs, has announced a partnership that will offer drug developers early bioavailability d...
Crystal Pharmatech Introduces Customized Service Packages for Customers Seeking Materials Science Approaches in Drug Discovery and Development
12 Dec 2012
Crystal Pharmatech Introduces Customized Service Packages for Customers Seeking Materials Science Approaches in Drug Discovery and Development
SUZHOU, China--(BUSINESS WIRE)--Crystal Pharmatech, one of the first solid state, technology-driven research laboratories to open in China adopting a Western approach to business and R&D, announce...
Contact Us
bd_global@crystalpharmatech.com +1-609-604-8303
U.S
Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey 08512, USA
Canada
6800 Kitimat Rd, Unit 1, Mississauga, Ontario, Canada L5N 5M1
China
Suite B4-101, Biobay, 218 Xinghu Street, Suzhou Industrial Park, Suzhou, China, 215123
Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey 08512, USA
bd_global@crystalpharmatech.com +1-609-604-8303